Medical Weight Loss Stuart
US$ 28.52
glp-1 receptor agonist nausea diarrhea management GI Adverse Effects of Glucagon-Like Peptide-1 Agonists GLP-1 Side Effects: Expert Tips
Description
This innovative compound
Lancet Diabetes & Endocrinology, 4(6), 525-536
While incretin-based therapies have been commercially available since 2005, most clinical trials only report short term outcomes
And that doesnt even take into account cardiovascular disease and diabetes
Anjana RM, Pradeepa R, Unnikrishnan R, Tiwaskar M, Aravind SR, Saboo B, Joshi SR, Mohan V
Results are expected in late 2025
